Cargando…
Efficacy of a Combined Treatment of Botulinum Toxin and Intensive Physiotherapy in Hereditary Spastic Paraplegia
INTRODUCTION: The Hereditary Spastic Paraplegia (HSP) is a heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and lower limbs (LL) weakness. There is no treatment to cure or halt the disease, except for symptomatic therapy. The use of botulinum toxin type A (B...
Autores principales: | Paparella, Gabriella, Vavla, Marinela, Bernardi, Lisa, Girardi, Giulia, Stefan, Cristina, Martinuzzi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046620/ https://www.ncbi.nlm.nih.gov/pubmed/32153352 http://dx.doi.org/10.3389/fnins.2020.00111 |
Ejemplares similares
-
Optical Coherence Tomography in a Cohort of Genetically Defined Hereditary Spastic Paraplegia: A Brief Research Report
por: Vavla, Marinela, et al.
Publicado: (2019) -
Brain Magnetic Spectroscopy Imaging and Hereditary Spastic Paraplegia: A Focused Systematic Review on Current Landmarks and Future Perspectives
por: Vavla, Marinela, et al.
Publicado: (2020) -
Clinical and Paraclinical Indicators of Motor System Impairment in Hereditary Spastic Paraplegia: A Pilot Study
por: Martinuzzi, Andrea, et al.
Publicado: (2016) -
Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX Trial
por: Nonnekes, Jorik, et al.
Publicado: (2021) -
ONLINE MONITORING OF FOCAL SPASTICITY TREATMENT WITH BOTULINUM TOXIN IN PEOPLE WITH CHRONIC STROKE OR HEREDITARY SPASTIC PARAPLEGIA: A FEASIBILITY STUDY
por: KERSTENS, Hans C. J. W., et al.
Publicado: (2023)